Our history

By establishing EspeRare, we fulfil our dream of dedicating our pharma expertise to children battling rare diseases.

Founders of EspeRare: Florence Porte, Caroline Kant, Béatrice Greco

EspeRare was founded in 2013 by 3 former pharmaceutical executives, who collectively have more than 50 years of experience in pharmaceutical development. They were animated by the urge to give a better life to children affected by rare diseases.

“Our courage, expertise and personal experience with rare disease patients, pushed us to become health innovators. We started our journey with one drug in Duchenne Muscular Dystrophy (DMD), and today, we have a portfolio of treatments that is targeting more than two million children suffering with rare diseases.”

“We share our warm gratitude to our community: partners, funders, organisations, foundations, families, patients that have so generously enabled this great adventure.”